SIRT1 and glioblastoma: Some studies have shown an increase in the level of SIRT1 in various tumors such as hepatocellular carcinoma, breast, prostate, ovarian, gastric, and colon cancer, leukemia, melanoma, lymphoma, and glioblastoma [8,9,10,11,12,13,14,15,16,17].